Skip to content
Search

Latest Stories

Low-fat vegan diet reduces insulin needs and lowers heart disease risk in diabetes patients

Participants on the low-fat vegan diet saw a 28 per cent drop in insulin needs and a remarkable 127 per cent boost in insulin sensitivity.

Low-fat vegan diet reduces insulin needs and lowers heart disease risk in diabetes patients

A recent study has revealed promising results regarding the efficacy of a low-fat vegan diet in managing Type 1 diabetes and reducing the risk of heart disease.

Conducted by researchers at the Physicians Committee for Responsible Medicine in the US and published in the Clinical Diabetes journal, the study sheds light on the potential benefits of adopting a plant-based diet for individuals with Type 1 diabetes.


Type 1 diabetes is an autoimmune condition characterised by the body's immune system attacking the pancreas, leading to impaired insulin production and blood sugar regulation.

Consequently, patients often require regular insulin injections to manage their condition. However, the study suggests that dietary interventions, particularly a low-fat vegan diet, may significantly reduce insulin needs and improve overall health outcomes.

low-fat-vegan-diet Hana Kahleova, MD, PhD (Photo credit: www.pcrm.org)

Lead author Hana Kahleova, Director of Clinical Research at the Physicians Committee for Responsible Medicine, highlights the groundbreaking nature of the research, emphasising its potential to alleviate concerns surrounding the cost of insulin and enhance the management of blood sugar levels in Type 1 diabetes patients.

The study involved 58 adults with Type 1 diabetes who were randomly assigned to either a low-fat vegan group or a portion-controlled group.

Over 12 weeks, participants following the low-fat vegan diet experienced a 28 per cent reduction in insulin requirements and a remarkable 127 per cent improvement in insulin sensitivity.

These effects were attributed to changes in body weight, with participants on the vegan diet experiencing an average weight loss of five kilograms.

Notably, the study found that increased carbohydrate and fibre intake associated with the vegan diet contributed to improved insulin sensitivity and reduced insulin requirements. These findings align with previous research linking lower fat and protein intake to better outcomes in Type 1 diabetes management.

Furthermore, the study explored the cardiovascular benefits of the low-fat vegan diet, as individuals with Type 1 diabetes are at higher risk of heart disease. The researchers observed significant reductions in total cholesterol and LDL cholesterol levels among participants in the vegan group, translating to a decreased risk of cardiovascular events such as heart attack and stroke.

While acknowledging the need for larger trials to validate these findings, the study shows the potential of a low-fat vegan diet as a holistic approach to managing Type 1 diabetes and reducing associated cardiovascular risks.

More For You

The Sattva Collective launches to support South Asian women

The initiative will empower more women to speak openly about their health

iStock

The Sattva Collective launches to support South Asian women through midlife and menopause

A new community-led initiative has been launched in the UK to provide culturally sensitive support for South Asian women navigating midlife and menopause.

The Sattva Collective, founded by certified Midlife and Menopause Coach Kiran Singh, officially launched on 14 May 2025 as a registered Community Interest Company (CIC). It is the first initiative in the UK focused specifically on the experiences of South Asian women during what Singh describes as a “deeply personal and often stigmatised” phase of life.

Keep ReadingShow less
Bella Hadid

Bella Hadid stuns at the Cannes Film Festival 2025 in a daring Saint Laurent black gown

Instagram/ Vogue France

Bella Hadid pushes Cannes 2025 dress code to the edge in a daring Saint Laurent black gown

Bella Hadid’s return to the Cannes Film Festival was anything but quiet. This year, the model showed up ready to challenge the red carpet rules without actually breaking them.

With new restrictions in place like no sheer fabrics, no visible nudity, no dramatic trains or bulky silhouettes, fashion-watchers wondered if Bella, known for her daring Cannes looks in the past, would tone it down. Instead, she found a clever way around the rules.

Keep ReadingShow less
Gen Z

These terms provide insight into how Gen Z views the world around them

iStock

11 Gen Z slang terms that have already peaked in 2025

Language is constantly evolving, and nowhere is this more apparent than in the lexicon of Gen Z. As the first generation to grow up fully immersed in social media, their language is influenced by memes, viral videos, and digital culture. With 2025 underway, several Gen Z slang terms have already become ubiquitous, appearing in everyday conversations, on social media platforms, and even in mainstream media. Here are 11 slang terms that have already peaked this year.

1. Delulu

"Delulu," short for "delusional," is one of the most prominent slang terms of 2025. It’s used to describe someone who holds unrealistic beliefs or makes outlandish claims. The term was catapulted into the spotlight after Australian Prime Minister Anthony Albanese used it in Parliament to describe his political opponents, referring to them as being "delulu with no solulu," which translates to "delusional with no solution." The term has since been widely adopted by young people, particularly in online communities. It’s now frequently used to poke fun at someone’s exaggerated or disconnected views on social media.

Keep ReadingShow less
FDA Urges Immediate Stop to Use of Recalled Eye Care Products

The FDA has categorised the recall as a Class II

iStock

Eye care products recalled across US over sterility concerns, FDA warns users to stop immediately

A nationwide recall of five eye care products has been issued in the United States after concerns were raised about their sterility and manufacturing standards. BRS Analytical Services, LLC, the manufacturer of the affected products, has urged consumers to stop using them immediately due to potential safety risks.

The recall, shared in a press release by healthcare distributor AvKARE, affects more than 1.8 million cartons of eye drops. The US Food and Drug Administration (FDA) identified multiple violations during a recent audit, including failures to meet Current Good Manufacturing Practice (CGMP) standards.

Keep ReadingShow less
Zepbound Surpasses Wegovy in Groundbreaking Weight Loss Study

This may influence future decisions on treatment options for obesity patients

iStock

Eli Lilly's Zepbound outshines Wegovy in weight loss trial results

Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.

This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.

Keep ReadingShow less